Identification of axonal involvement in Hallervorden-Spatz disease with magnetic resonance spectroscopy

被引:5
|
作者
Kitis, O.
Tekgul, H. [1 ]
Erdemir, G.
Polat, M.
Serdaroglu, G.
Tosun, A.
Coker, M.
Gokben, S.
机构
[1] Ege Univ Hosp, Dept Pediat, Div Pediat Neurol, TR-35100 Izmir, Turkey
[2] Ege Univ Hosp, Dept Radiol, Div Neuroradiol, TR-35100 Izmir, Turkey
[3] Ege Univ Hosp, Dept Pediat, Div Endocrinol & Metab, TR-35100 Izmir, Turkey
关键词
Hallervorden-Spatz syndrome; neurodegenerative diseases; magnetic resonance imaging; magnetic resonance spectroscopy;
D O I
10.1016/S0150-9861(06)77244-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hallervorden-Spatz disease is a neurodegenerative disorder associated with cysteine-iron complex accumulation typically seen as bilateral symmetrical hypointense signal changes in the medial globus pallidus on magnetic resonance imaging. We used magnetic resonance spectroscopy to identify and quantify neuronal damage in two siblings with Hallervorden-Spatz disease. The first patient presenting with a rapidly progressive extrapyramidal syndrome had markedly decreased Nacetylaspartate (NAA) to creatinine (Cr) ratios in the globus pallidi and the periatrial white matter. He also had increased myoinositol (ml) to creatinine (Cr) ratios implying glial proliferation in the affected regions. However the second patient who had the initial presentation of disease had normal NAA/Cr and ml/Cr ratios. These findings indicate that the quantification of NAA:Cr and ml:Cr ratios might be used to predict the extent of neuronal axonal loss and glial proliferation in patients with Hallervorden-Spatz disease respectively.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 50 条
  • [41] Recent observations of the Hallervorden-Spatz disease.
    Eicke, WJ
    ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1940, 111 (03): : 514 - 546
  • [42] ANESTHETIC MANAGEMENT OF A PATIENT WITH HALLERVORDEN-SPATZ DISEASE
    ROY, RC
    MCLAIN, S
    WISE, A
    SHAFFNER, LD
    ANESTHESIOLOGY, 1983, 58 (04) : 382 - 384
  • [43] IN-VIVO DIAGNOSIS OF HALLERVORDEN-SPATZ DISEASE
    OSTERGAARD, JR
    CHRISTENSEN, T
    HANSEN, KN
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1995, 37 (09): : 827 - 833
  • [44] Re: Status dystonicus and Hallervorden-Spatz disease
    Flett, PJ
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2004, 40 (12) : 721 - 721
  • [45] COMPUTED-TOMOGRAPHY IN HALLERVORDEN-SPATZ DISEASE
    DOOLING, EC
    RICHARDSON, EP
    DAVIS, KR
    NEUROLOGY, 1980, 30 (10) : 1128 - 1130
  • [46] LIVER AND PITUITARY ABNORMALITIES IN HALLERVORDEN-SPATZ DISEASE
    WILLIAMS, DJ
    IRONSIDE, JW
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1989, 52 (12): : 1410 - 1414
  • [47] Iron deposits in the subthalamic nuclei in Hallervorden-Spatz disease
    Muller, T
    Amoiridis, G
    Kuhn, W
    Przuntek, H
    EUROPEAN NEUROLOGY, 1999, 42 (04) : 240 - 241
  • [48] LATE ONSET PARKINSONIAN SYNDROME IN HALLERVORDEN-SPATZ DISEASE
    ALBERCA, R
    RAFEL, E
    CHINCHON, I
    VADILLO, J
    NAVARRO, A
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (12): : 1665 - 1668
  • [49] ELECTRON-PROBE MICROANALYSIS OF HALLERVORDEN-SPATZ DISEASE
    TUCKER, JA
    HOFFMAN, MR
    MCLENDON, RE
    INGRAM, P
    SHELBURNE, JD
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 85 (03) : 385 - 385